NMNAT-3 Inhibitors

NMNAT-3 inhibitors, in this context, refer to a variety of chemicals that can indirectly influence the activity of NMNAT-3 by targeting related pathways in NAD+ biosynthesis and metabolism. NMNAT-3 plays a critical role in the final step of NAD+ synthesis. The modulation of NMNAT-3 activity, therefore, involves influencing the availability or demand for NAD+ within cells. The first category includes inhibitors of NAMPT, such as FK866 and CHS-828. NAMPT is a key enzyme in the salvage pathway of NAD+ biosynthesis. By inhibiting NAMPT, these compounds reduce the overall levels of NAD+, impacting the functional dynamics of NMNAT-3.

Another important category consists of sirtuin inhibitors like Sirtinol, EX-527, and Nicotinamide. Sirtuins are a family of NAD+-dependent deacetylases, and their inhibition can influence NAD+ metabolism and availability, indirectly affecting NMNAT-3 activity. Additionally, compounds affecting nucleotide metabolism, such as 3-AP and Gallotannin, might indirectly modulate NMNAT-3 activity. These inhibitors target ribonucleotide reductase, an enzyme involved in the synthesis of deoxyribonucleotides, thereby influencing nucleotide pools and indirectly affecting pathways where NMNAT-3 is involved. Natural compounds like Quercetin, Curcumin, Resveratrol, and Berberine, with their broad spectrum of biological activities, can also indirectly impact NMNAT-3.